Covariates | Pre cfEBV DNA | Post-NAC MRI | Post-NAC cfEBV DNA | Response phenotypes |
---|
UN | IPWa | UN | IPWb | UN | IPWb | UN | IPWb |
---|
Age | 0.51 | 0.59 | 0.58 | 0.83 | 0.19 | 0.85 | 0.14 | 0.59 |
Sex | 0.71 | 0.53 | 0.15 | 0.58 | 0.18 | 0.77 | 0.08 | 0.16 |
Smoking | 0.37 | 0.82 | 0.36 | 0.74 | 0.11 | 0.99 | 0.17 | 0.43 |
Alcohol | 0.96 | 0.70 | 0.59 | 0.86 | 0.68 | 0.77 | 0.32 | 0.52 |
Pre cfEBV DNA | – | – | 0.76 | 0.76 | <0.01 | 0.99 | <0.01 | 0.14 |
T stage | 0.43 | 0.94 | 0.57 | 0.65 | 0.42 | 0.80 | <0.01 | 0.23 |
N stage | <0.01 | 0.87 | 0.72 | 0.46 | <0.01 | 0.94 | <0.01 | 0.10 |
NAC cycles | 0.94 | 0.95 | 0.02 | 0.40 | 0.17 | 0.97 | 0.02 | 0.22 |
NAC regimens | 0.12 | 0.97 | <0.01 | 0.29 | 0.27 | 0.87 | 0.03 | 0.09 |
CCD | 0.71 | 0.46 | 0.27 | 0.29 | 0.53 | 0.83 | 0.03 | 0.10 |
- Abbreviations: CCD Cumulative cisplatin doses, cfEBV DNA Cell-free Epstein-Barr virus DNA, IPW Inverse probability weighting, MRI Magnetic resonance imaging, N Node, NAC Neoadjuvant chemotherapy, Pre Pretreatment, T Tumor, UN Unadjusted
- aThe following variables were adjusted via IPW algorithm: age (<45 vs. ≥45 years), sex (male vs. female), smoking (No vs. Yes), alcohol (No vs. Yes), T stage (T1-2 vs. T3-4), N stage (N0-1 vs. N2-3), NAC regimens (TPF vs. GP vs. TP vs. PF vs. others), NAC cycles (2 cycles vs. 3 cycles vs. 4 cycles), CCD (<160vs. ≥160 mg/m2). Two-sided P-values were calculated using the chi-square test
- bThe following variables were adjusted via IPW algorithm: age (<45 vs. ≥45 years), sex (male vs. female), smoking (No vs. Yes), alcohol (No vs. Yes), pretreatment EBV DNA (<2 vs. ≥2 × 103 copies/mL), T stage (T1-2 vs. T3-4), N stage (N0-1 vs. N2-3), IC regimens (TPF vs. GP vs. TP vs. PF vs. others), IC cycles (2 cycles vs. 3 cycles vs. 4 cycles), CCD (<160 vs. ≥160 mg/m2). Two-sided P-values were calculated using the chi-square test